Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

1. Tuñón, J.
2. Fernández-Fernández, B.
3. Carda, R.
4. Pello, A.M.
5. Cristóbal, C.
6. Tarín, N.
7. Aceña, Á.
8. González-Casaus, M.L.
9. Huelmos, A.
10. Alonso, J.
11. Lorenzo, Ó.
12. González-Parra, E.
13. Hernández-González, I.
14. Mahíllo-Fernández, I.
15. López-Bescós, L.
16. Egido, J.